Malcolm John Mccomas's Trading History
| ATGGFActinogen Medical | Aug 17, 2026 | Director | Uninformative Sell | 7.53K | $408.52K | |
| KIOFitzroy River Corp. Ltd. | Apr 21, 2023 | Director | Informative Buy | 65.00K | €427.35K | |
| SNTSyntara Limited | Dec 23, 2021 | Director | Informative Buy | 112.75K | AU$44.59K | |
| SNDSaunders International Limited | Oct 18, 2017 | Director | Informative Buy | 4.63K | AU$64.94K | |
| BIRNFBCI Minerals Ltd | Jan 30, 2013 | Director | Informative Buy | 11.83K | $10.57K |
You May Also Like
Malcolm John Mccomas insider profile FAQ
What is the percentage of profitable transactions made by Malcolm John Mccomas?
The percentage of profitable transactions made by Malcolm John Mccomas is 31%.
What is the average return per transaction made by Malcolm John Mccomas?
The average return per transaction made by Malcolm John Mccomas is -14.40%.
What stocks does Malcolm John Mccomas hold?
Malcolm John Mccomas holds: ATGGF, BIRNF, DE:KIO, AU:SND, AU:SNT stocks.
What was Malcolm John Mccomas’s latest transaction?
Malcolm John Mccomas’s latest transaction was an Uninformative Sell of $7.53K.
What was Malcolm John Mccomas's most profitable transaction?
Malcolm John Mccomas’s most profitable transaction was an Informative Buy of DE:KIO stock on March 23, 2021. The return on the trade was 8.60%.
What is Malcolm John Mccomas's role in Actinogen Medical ?
Malcolm John Mccomas's role in Actinogen Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.